Breast Cancer Continues to Be a Large Part of the Discussion at ASCO 2015

At ASCO 2015, health care providers (HCPs) discussed a number of tumor types and clinical trials. Breast cancer continued to be one of the top three tumors discussed at the conference. While in 2014 it was the top tumor type discussed, this year it was second. The volume of tweets about breast cancer grew by 73%, with 21% of these coming from HCPs and only 5% coming from patients and support groups. Not surprisingly, the Paloma-3 trial was the most discussed clinical trial in breast cancer, where 66% of HCPs who tweeted shared positive opinions about the trial.

An overview of ASCO social media trends is available in the infographic Key Social-Media Trends at ASCO 2015.


Download this infographic.